Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damiana Costin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Personalized Medicine|May 25, 2024
Non-Invasive Retinal Vessel Analysis as a Predictor for Cardiovascular DiseaseRaluca Eugenia Iorga, Damiana Costin, Răzvana Sorina Munteanu-Dănulescu, et al.
International Journal of Molecular Sciences|June 10, 2023
Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?Patricia Richter, Anca Cardoneanu, Nicoleta Dima, et al.
Journal of Clinical Medicine|August 14, 2025
Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot StudyDiana Popescu, Minerva Codruta Badescu, Elena Rezus, et al.
International Journal of Molecular Sciences|July 13, 2024
Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic FactorsDamiana Costin, Alexandra Maria Burlui, Anca Cardoneanu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Personalized Medicine|May 25, 2024
Non-Invasive Retinal Vessel Analysis as a Predictor for Cardiovascular DiseaseRaluca Eugenia Iorga, Damiana Costin, Răzvana Sorina Munteanu-Dănulescu, et al.
International Journal of Molecular Sciences|June 10, 2023
Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?Patricia Richter, Anca Cardoneanu, Nicoleta Dima, et al.
Journal of Clinical Medicine|August 14, 2025
Cardiovascular Risk in Rheumatic Patients Treated with JAK Inhibitors: The Role of Traditional and Emerging Biomarkers in a Pilot StudyDiana Popescu, Minerva Codruta Badescu, Elena Rezus, et al.
International Journal of Molecular Sciences|July 13, 2024
Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic FactorsDamiana Costin, Alexandra Maria Burlui, Anca Cardoneanu, et al.
Pageof 1